Santa Cruz Biotechnology provides a broad selection of RT1-B α monoclonal antibodies for advanced research in immunology and cellular biology. RT1-B α monoclonal antibodies are highly effective in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RT1-B α is a crucial component of the major histocompatibility complex (MHC) class I molecules, playing a significant role in the immune response by presenting peptide antigens to CD8+ T cells. RT1-B α functions in the recognition of self and non-self antigens, influencing the activation and regulation of immune responses. Understanding RT1-B α functionality provides valuable insights into autoimmune diseases, transplant rejection, and cancer immunotherapy. Researchers can utilize RT1-B α monoclonal antibodies to investigate cellular pathways and molecular mechanisms involved in immune system regulation. Advanced research with RT1-B α monoclonal antibodies supports the development of novel therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding and contribute to breakthrough discoveries in immunology research.